Lyme Research Pioneer Dr. Daniel Cameron on Lyme Time with Ali
What is the latest in conventional medicine for Lyme and tick-borne illness patients? I sat down with Dr. Daniel Cameron who is one of the early pioneers in Lyme disease research and past president of ILADS to talk turkey about antibiotics and how he trains other MD’s to be Lyme-literate.
His interest in research and teaching continues at his private practice where he manages the Lyme Disease Practice and Research (LDPR) project and mentors health care practitioners interested in learning more about Lyme and tick-borne diseases. Physicians and practitioners, from across the country, visit his office to receive on-site training and education in diagnosing and treating all stages of Lyme disease. Meanwhile, ongoing clinical trials are performed through the LDPR in an effort to improve the level of care for Lyme disease patients.
We covered a TON of information here including PICC lines, different antibiotics and their efficacy with Lyme, why professionals continue to miss proper diagnosis, how he handles Herxheimer reactions with patients, what has changed over the last 30 years and what is on the horizon for treatments. We also covered results from a new endeavor for him: LYME DISEASE AND COVID VACCINES. You can take that survey on his website. Yep, he’s doing research in that area, too!
I could write about what this legend offers to our community all day. However, you can find it all on his website. To hear the Lyme Time podcast, click here.
What an honor to talk with him! I hope you find time to listen to someone who has truly paved the way and brought a humanitarian aspect to his specialty, Lyme disease.
Be well,
Ali
